News
National Jewish, Brigham and Women's hospitals Awarded NHLBI Grant of $37 Million for COPD Research
DENVER—Researchers from National Jewish Medical and Research Center and Brigham and Women’s Hospital have been awarded a $37 million grant from the National Heart Lung and Blood Institute (NHLBI) to lead the most comprehensive study of chronic obstructive pulmonary disease (COPD) ever undertaken. The multi-institutional study will seek to identify the genetic, epidemiological and radiological characteristics of COPD, with a long-term goal of better understanding the disease and finding more effective treatments.
“COPD is the fourth leading cause of death in the United States, and yet we know so little about the disease,” said James Crapo, MD, professor of medicine at National Jewish and co-principal investigator of the study. “This study will help us determine which smokers are most at risk of developing the disease, who is most likely to have progressive disease, and how to more effectively treat it.”
“Our goal with this massive project is to discover genes responsible for this chronic lung disease and to develop a comprehensive data sharing plan so that this study will become a national resource for the scientific community,” said Edwin Silverman, MD, PhD, associate professor of medicine at BWH and co- principal investigator of the study.
To read full article, click here.
